Your browser doesn't support javascript.
COVID-19 and cardiovascular disease: a review of current knowledge.
Pal, Aastha; Ahirwar, Ashok Kumar; Sakarde, Apurva; Asia, Priyanka; Gopal, Niranjan; Alam, Sana; Kaim, Kirti; Ahirwar, Pradeep; Sorte, Smita R.
  • Pal A; All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
  • Ahirwar AK; Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
  • Sakarde A; Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
  • Asia P; Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
  • Gopal N; Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
  • Alam S; Department of Biochemistry, Hamdard Institute of Medical Sciences and Research, New Delhi, India.
  • Kaim K; Department of Ophthalmology, Indira Gandhi ESI Hospital, New Delhi, India.
  • Ahirwar P; Indira Gandhi Hospital, Bhopal, Madhya Pradesh, India.
  • Sorte SR; Department of Physiology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Horm Mol Biol Clin Investig ; 42(1): 99-104, 2021 Feb 04.
Article in English | MEDLINE | ID: covidwho-1067447
ABSTRACT
The uncontrolled spread of the COVID-19 pandemic which originated in China created a global turmoil. While the world is still busy figuring out a cure for the deadly disease, scientists worked out on many theories and conducted several studies to establish a relationship between the infection and other known diseases. Cardiovascular diseases (CVD) are one of the major complications of this infection after the respiratory manifestations. Individuals with cardiovascular complication are said to be more susceptible to acquiring the infection because the novel coronavirus uses the ACE2 receptor for its entry inside the cell and there is a high level of ACE2 expression in individuals with cardiovascular complications because of the enzyme's anti-hypertrophic, anti-fibrotic and anti-hypertensive effects on the heart. Individuals who belong to the older age group are also more susceptible. Knowing the above information, it might seem that using ACE2 inhibitors would help to slow or prevent the entry of the novel coronavirus but it would also at the same time prove to have deleterious effects on the cardiovascular system as the protective functions of ACE2 would be lost. While the search for a cure still continues it has been stated many a times that the conditions might worsen with time and the only way to keep ourselves and our family safe would be to follow the appropriate social distancing methods and get a COVID test if we experience any of the major symptoms.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Humans / Middle aged Language: English Journal: Horm Mol Biol Clin Investig Year: 2021 Document Type: Article Affiliation country: Hmbci-2020-0052

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Humans / Middle aged Language: English Journal: Horm Mol Biol Clin Investig Year: 2021 Document Type: Article Affiliation country: Hmbci-2020-0052